Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jun-22 6:04 PM View:  | Standard Biotools Inc. (LAB) | 15-Jun-22 | Grant | 30,914 | -- | -- | 65% 47.5K to 78.42K | |
| 12-May-22 8:45 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Sale (Planned) | 1,375 | $21.51 | $29,576.20 | (4%) 37.03K to 35.66K | |
| 12-May-22 8:45 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-22 | Sale (Planned) | 825 | $21.51 | $17,745.80 | (2%) 37.85K to 37.03K | |
| 27-Apr-22 7:02 PM View: | American Technology Corp. (GNSS) | 27-Apr-22 | Option Exercise | 50,000 | $1.33 | $66,500.00 | 21% 236.31K to 286.31K | |
| 17-Mar-22 3:36 PM View: | American Technology Corp. (GNSS) | 15-Mar-22 | Grant | 30,000 | -- | -- | 15% 206.31K to 236.31K | |
| 24-Feb-22 1:54 PM View: | American Technology Corp. (GNSS) | 23-Feb-22 | Option Exercise | 20,000 | $2.16 | $43,200.00 | 10% 200.03K to 220.03K | |
| 24-Feb-22 1:54 PM View: | American Technology Corp. (GNSS) | 23-Feb-22 | Option Sale | 13,716 | $3.14 | $43,068.20 | (6%) 220.03K to 206.31K | |
| 02-Feb-22 4:17 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Grant | 9,840 | -- | -- | 34% 29.25K to 39.09K | |
| 02-Feb-22 4:17 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Sale (Planned) | 1,238 | $27.40 | $33,921.20 | (3%) 39.09K to 37.85K | |
| 26-Jan-22 4:34 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-22 | Market Sale (Planned) | 2,063 | $24.98 | $51,533.70 | (7%) 31.32K to 29.25K | (12%) |
| 12-Jan-22 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Jan-22 | Sale (Planned) | 7,500 | $27.40 | $205,500.00 | (19%) 38.82K to 31.32K | |
| 12-Jan-22 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-Jan-22 | Grant | 7,500 | -- | -- | 24% 31.32K to 38.82K | |
| 27-May-21 5:28 PM View: | Standard Biotools Inc. (LAB) | 25-May-21 | Grant | 10,342 | -- | -- | 28% 37.16K to 47.5K | |
| 13-May-21 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-21 | Market Sale (Planned) | 2,000 | $19.46 | $38,920.00 | (7%) 30.22K to 28.22K | < 1% |
| 13-May-21 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-21 | Market Sale (Planned) | 2,000 | $19.14 | $38,280.00 | (6%) 32.22K to 30.22K | (4%) |
| 18-Mar-21 4:52 PM View: | American Technology Corp. (GNSS) | 16-Mar-21 | Grant | 27,883 | -- | -- | 20% 140.14K to 168.03K | |
| 12-Mar-21 12:43 PM View: | American Technology Corp. (GNSS) | 10-Mar-21 | Option Exercise | 20,000 | $2.02 | $40,400.00 | 13% 155.6K to 175.6K | |
| 12-Mar-21 12:43 PM View: | American Technology Corp. (GNSS) | 10-Mar-21 | Market Option Sale | 5,456 | $7.42 | $40,465.00 | (3%) 175.6K to 170.14K | |
| 23-Feb-21 9:58 PM View: | Standard Biotools Inc. (LAB) | 20-Feb-21 | Grant | 9,803 | -- | -- | 36% 27.36K to 37.16K | |
| 09-Feb-21 4:29 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Feb-21 | Market Sale (Planned) | 2,250 | $31.58 | $71,055.00 | (7%) 34.47K to 32.22K | 2% |
| 09-Feb-21 4:29 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Feb-21 | Market Sale (Planned) | 2,250 | $31.41 | $70,672.50 | (6%) 36.72K to 34.47K | (1%) |
| 05-Feb-21 4:46 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Grant | 4,500 | -- | -- | 14% 32.22K to 36.72K | |
| 03-Feb-21 9:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Market Sale (Planned) | 3,625 | $28.91 | $104,799.00 | (10%) 35.85K to 32.22K | < 1% |
| 02-Feb-21 9:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Sale (Planned) | 3,625 | $30.75 | $111,469.00 | (9%) 39.47K to 35.85K | |
| 02-Feb-21 9:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-21 | Grant | 5,000 | -- | -- | 15% 34.47K to 39.47K | |
| 25-Jan-21 8:55 PM View: | Travere Therapeutics, Inc. (TVTX) | 21-Jan-21 | Grant | 15,000 | -- | -- | 77% 19.47K to 34.47K | |
| 25-Nov-20 7:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 25-Nov-20 | Market Sale (Planned) | 3,750 | $22.72 | $85,200.00 | (16%) 23.22K to 19.47K | |
| 25-Nov-20 7:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Nov-20 | Market Sale (Planned) | 3,750 | $23.86 | $89,475.00 | (14%) 26.97K to 23.22K | |
| 25-Nov-20 7:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Nov-20 | Grant | 7,500 | -- | -- | 39% 19.47K to 26.97K | |
| 17-Nov-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Nov-20 | Market Sale (Planned) | 7,500 | $23.98 | $179,812.00 | (28%) 26.97K to 19.47K | |
| 13-Nov-20 9:24 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-Nov-20 | Market Sale (Planned) | 7,500 | $23.61 | $177,071.00 | (22%) 34.47K to 26.97K | |
| 13-Nov-20 9:24 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Nov-20 | Grant | 15,000 | -- | -- | 77% 19.47K to 34.47K | |
| 23-Sep-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Sep-20 | Market Sale (Planned) | 1,500 | $18.48 | $27,720.00 | (7%) 20.97K to 19.47K | (5%) |
| 22-Sep-20 9:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 22-Sep-20 | Market Sale (Planned) | 1,500 | $18.59 | $27,885.00 | (7%) 22.47K to 20.97K | |
| 22-Sep-20 9:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Sep-20 | Grant | 3,000 | -- | -- | 15% 19.47K to 22.47K | |
| 25-Jun-20 3:59 PM View: | Standard Biotools Inc. (LAB) | 23-Jun-20 | Grant | 13,369 | -- | -- | 96% 13.99K to 27.36K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale | 527 | $16.98 | $8,950.73 | (2%) 21.25K to 20.72K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale (Planned) | 1,250 | $17.16 | $21,450.00 | (6%) 20.72K to 19.47K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-20 | Market Sale (Planned) | 1,250 | $14.95 | $18,687.50 | (6%) 22.5K to 21.25K | |
| 12-Mar-20 6:49 PM View: | American Technology Corp. (GNSS) | 12-Mar-20 | Option Exercise | 30,000 | -- | -- | 24% 125.6K to 155.6K | |
| 12-Mar-20 6:49 PM View: | American Technology Corp. (GNSS) | 10-Mar-20 | Grant | 30,000 | -- | -- | 31% 95.6K to 125.6K | |
| 12-Mar-20 7:43 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-Mar-20 | Market Sale (Planned) | 4,000 | $15.02 | $60,080.00 | (15%) 26.5K to 22.5K | |
| 09-Mar-20 9:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Mar-20 | Grant | 4,000 | -- | -- | 18% 22.5K to 26.5K | |
| 31-Jan-20 8:15 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-20 | Grant | 9,000 | -- | -- | 67% 13.5K to 22.5K | |
| 05-Jun-19 1:38 PM View: | Standard Biotools Inc. (LAB) | 03-Jun-19 | Grant | 3,987 | -- | -- | 40% 10.0K to 13.99K | |
| 16-May-19 9:37 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-May-19 | Market Sale (Planned) | 1,250 | $18.71 | $23,387.50 | (8%) 14.75K to 13.5K | < 1% |
| 16-May-19 9:37 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-19 | Market Sale (Planned) | 1,250 | $17.78 | $22,225.00 | (8%) 16.0K to 14.75K | (4%) |
| 10-May-19 9:40 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-19 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 20-Mar-19 7:17 PM View: | American Technology Corp. (GNSS) | 20-Mar-19 | Option Exercise | 25,000 | -- | -- | 34% 72.6K to 97.6K | |
| 13-Feb-19 8:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-Feb-19 | Market Sale (Planned) | 1,016 | $21.50 | $21,844.00 | (9%) 11.02K to 10.0K | (3%) |